Zevia (ZVIA)
(Delayed Data from NYSE)
$3.28 USD
+0.04 (1.23%)
Updated Aug 5, 2025 04:00 PM ET
After-Market: $3.28 0.00 (0.00%) 7:58 PM ET
4-Sell of 5 4
F Value A Growth D Momentum C VGM
Fundamental Charts
About PEG Ratio (TTM)
The company's trailing twelve month (TTM) PEG ratio is the P/E ratio divided by its long-term growth rate consensus. This ratio essentially compares the P/E to its growth rate, thus, for many, telling a more complete story than just the P/E ratio alone. Conventional wisdom says that a PEG ratio of 1 or less is considered good (at par or undervalued to its growth rate). A value greater than 1, in general, is not as good (overvalued to its growth rate). For example, a company with a P/E ratio of 25 and a growth rate of 20% would have a PEG ratio of 1.25 (25 / 20 = 1.25). A company with a P/E ratio of 40 and a growth rate of 50% would have a PEG ratio of 0.80 (40 / 50 = 0.80). Traditionally, investors would look at the stock with the lower P/E and deem it a bargain. But when compared to its growth rate, it doesn't have the earnings growth to justify its P/E. In this example, the one with the P/E of 40 is the better bargain because it is selling at a discount to its growth rate. So the PEG ratio tells you what you're paying for each unit of earnings growth.
ZVIA 3.28 +0.04(1.23%)
Will ZVIA be a Portfolio Killer in August?
Zacks Investment Research is releasing its prediction for ZVIA based on the 1-3 month trading system that more than doubles the S&P 500.
Zacks News for ZVIA
AB InBev Q2 Earnings Beat Estimates, Revenues Miss on Soft Volumes
FEMSA Q2 Earnings & Revenues Miss Estimates, Mexico Operations Hurt
ZVIA: What are Zacks experts saying now?
Zacks Private Portfolio Services
Boston Beer Q2 Earnings Beat & Raised '25 Outlook Fuel Stock Gains
Keurig Q2 Earnings Meet Estimates, U.S. Refreshing Beverages Up 10.5%
Keurig Dr Pepper, Inc (KDP) Meets Q2 Earnings Estimates
Other News for ZVIA
Earnings Scheduled For August 6, 2025
Earnings to Watch: Zevia PBC (ZVIA) Reports Q2 2025 Result
Ralph Lauren To Rally Around 14%? Here Are 10 Top Analyst Forecasts For Monday
This Alnylam Pharmaceuticals Analyst Is No Longer Bearish; Here Are Top 5 Upgrades For Monday
ZVIA Stock Upgraded to Outperform with Increased Price Target | ZVIA Stock News